Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796375 · ClinicalTrials.gov registry record · Phase 2
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
A Phase 2 study of Non-muscle Invasive Bladder Cancer, sponsored by White River Junction Veterans Affairs Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 8
- Study locations
NCT05796375 is a Phase 2 study of Non-muscle Invasive Bladder Cancer that is actively recruiting participants, run by White River Junction Veterans Affairs Medical Center. The registered enrollment target is 240 participants, roughly in line with the 225-participant average among 28 other Non-muscle Invasive Bladder Cancer trials with a reported enrollment target. The trial reports 8 study locations across 8 states.
The verdict
NCT05796375, a Phase 2 study of Non-muscle Invasive Bladder Cancer, is actively recruiting participants, sponsored by White River Junction Veterans Affairs Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, complications, cancer recurrence or cancer progression when some cystoscopy procedures are replaced with urine testing.
Conditions Studied
Interventions
- PROCEDURE Cystoscopy
- DIAGNOSTIC_TEST Bladder EpiCheck urine test
- DIAGNOSTIC_TEST Xpert Bladder Cancer Monitor urine test
Study Locations (8)
Connecticut
- West Haven VA Medical Center - West Haven
Florida
- Bay Pines VA Healthcare System - Bay Pines
Massachusetts
- VA Boston Jamaica Plains Campus - West Roxbury
Missouri
- VA St.Louis Healthcare System - St Louis
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
South Carolina
- Medical University of South Carolina - Charleston
Texas
- UT Southwestern Medical Center - Dallas
Vermont
- White River Junction Veterans Healthcare System - White River Junction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-11-17 |
| Est. Completion | 2028-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796375
The ClinicalTrials.gov registry entry for NCT05796375 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 225-participant average among 28 other Non-muscle Invasive Bladder Cancer trials with a reported enrollment target. The listed sponsor is White River Junction Veterans Affairs Medical Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-muscle Invasive Bladder Cancer appearing as the primary indexed condition, and to 3 interventions - of which Cystoscopy is the first listed.
NCT05796375 reports 8 study locations spanning 8 distinct geographic areas - top geographies include Connecticut, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05796375 about?
NCT05796375 is a clinical study titled "Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance". The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether there are any differences in urinary symptoms, discomfort, number of invasive procedures, anxiety, comp...
What is the current status of trial NCT05796375?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2023-11-17. Estimated completion is 2028-12-30.
What conditions does trial NCT05796375 study?
This clinical trial studies the following conditions: Non-muscle Invasive Bladder Cancer.
What interventions are being tested in trial NCT05796375?
The interventions under investigation include: Cystoscopy (PROCEDURE), Bladder EpiCheck urine test (DIAGNOSTIC_TEST), Xpert Bladder Cancer Monitor urine test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05796375?
This trial is sponsored by White River Junction Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796375 being conducted?
This trial has 8 study locations across Connecticut, Florida, Massachusetts, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-muscle Invasive Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RECRUITING · Phase 2
-
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
RECRUITING · Phase 2
-
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
RECRUITING · Phase 2
-
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
COMPLETED · Phase 2
-
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
RECRUITING · Phase 1
-
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.